Zetia and Pyogenic liver abscess - a phase IV clinical study of FDA data

Summary:

Pyogenic liver abscess is reported only by a few people who take Zetia.

The phase IV clinical study analyzes which people take Zetia and have Pyogenic liver abscess. It is created by eHealthMe based on reports of 45,364 people who have side effects while taking Zetia from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 02, 2022

45,364 people reported to have side effects when taking Zetia.
Among them, 4 people (0.01%) have Pyogenic liver abscess.

What is Zetia?

Zetia has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 46,599 Zetia users for its effectiveness, alternative drugs and more.

What is Pyogenic liver abscess?

Pyogenic liver abscess (liver abscess caused by bacteria) is found to be associated with 1,196 drugs and 819 conditions by eHealthMe.

Number of Zetia and Pyogenic liver abscess reports submitted per year:

Could Zetia cause Pyogenic liver abscess?

Gender of people who have Pyogenic liver abscess when taking Zetia *:

female: 0.0 %
male: 100 %

Age of people who have Pyogenic liver abscess when taking Zetia *:

Common drugs people take besides Zetia *:

Common side effects people have besides Pyogenic liver abscess *:

Fever: 3 people, 75.00%
Septic Shock (shock due to blood infection): 3 people, 75.00%
Diabetes: 2 people, 50.00%
Weakness: 1 person, 25.00%
Deformity (disfigurement): 1 person, 25.00%
Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 1 person, 25.00%
Hyperhidrosis (abnormally increased sweating): 1 person, 25.00%
Hepatic Steatosis (fatty liver disease): 1 person, 25.00%
Heart Attack: 1 person, 25.00%
Gynecomastia (enlargement of the gland tissue of the male breast): 1 person, 25.00%

Common conditions people have *:

Prinzmetal Angina (cardiac chest pain at rest that occurs in cycles): 3 people, 75.00%
Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 3 people, 75.00%
Fever: 3 people, 75.00%
Dyslipidaemia (abnormal amount of lipids): 3 people, 75.00%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 75.00%
Metastases To Bone (cancer spreads to bone): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Zetia and have Pyogenic liver abscess?

Check whether Pyogenic liver abscess is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Pyogenic liver abscess and when was it recovered:

Pyogenic liver abscess in Zetia

Expand to all the drugs that have ingredients of ezetimibe:

Pyogenic liver abscess and drugs with ingredients of ezetimibe

Alternative drugs to, pros and cons of Zetia:

Zetia (46,599 reports)

Common Zetia side effects:

Fatigue (feeling of tiredness): 2,774 reports
Muscle aches (muscle pain): 2,585 reports
Weakness: 2,563 reports
Dizziness: 2,230 reports
Diarrhea: 2,141 reports
Pain: 2,126 reports
Drug ineffective: 2,086 reports

Browse all side effects of Zetia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Pyogenic liver abscess treatments and more:

Pyogenic liver abscess (4,123 reports)

COVID vaccines that are related to Pyogenic liver abscess:

Common drugs associated with Pyogenic liver abscess:

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe (the active ingredients of Zetia) and Zetia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.